ATC code V
Source: Wikipedia, the free encyclopedia.
Pharmaceutical drug classification
ATC code V: Various |
---|
|
Other ATC codes |
ATC code V Various is a section of the
Codes for
ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QV.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
References
- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ^ "ATC/DDD Index 2022: code V". WHO Collaborating Centre for Drug Statistics Methodology.
- ^ "ATCvet Index 2022: code QV". WHO Collaborating Centre for Drug Statistics Methodology.
Nervous system | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Circulatory system |
| ||||||||||||||
Other |
| ||||||||||||||
Emetic |
| ||||||||||||||
|
Copper | |
---|---|
Iron | |
Lead | |
Thallium | |
Other | |
|
|
| |
---|---|---|
Uric acid (TLS) | ||
Acrolein / nitrogen mustards | ||
Iron / anthracyclines | ||
Alkylating agents | ||
Keratinocyte growth factor |
| ||
---|---|---|
Treatment of hypoglycaemia | ||
Medical gases |
| ||
---|---|---|
Fat absorption |
| |
Bile duct patency | ||
Liver functional capacity | ||
Gastric secretion | ||
Exocrine pancreatic function |
Pituitary function | |
---|---|
Thyroid function | |
Fertility disturbances |
Renal function
| ||
---|---|---|
Nephrotropic, low osmolar | ||
Hepatotropic |
Water insoluble
- Ethyl esters of iodised fatty acids, lipiodol)
- Iopydol
- Propyliodone
- Iofendylate‡
Paramagnetic
- Gadolinium-based: Gadobenic acid
- Gadobutrol
- Gadodiamide
- Gadofosveset
- Gadolinium
- Gadopentetic acid
- Gadopiclenol
- Gadoteric acid
- Gadoteridol
- Gadoversetamide
- Gadoxetic acid
- Other: Ferric ammonium citrate
- Mangafodipir‡
- Microspheres of human albumin
- Microparticles of galactose
- Perflenapent
- Microspheres of phospholipids
- Sulfur hexafluoride
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
Therapeutic radiopharmaceuticals (V10) | |||||
---|---|---|---|---|---|
Pain palliation |
| ||||
Adrenergic tumors | |||||
CD20 antibodies | |||||
Radionuclides |
| ||||
Isotopes used:
See also: Diagnostic radiopharmaceuticals (V09)
|